While 97% of Americans who received a prescription for medication in the last 90 days filled it, the most-cited reason among respondents who did not fill their prescription was cost (67%), according to the Truven Health Analytics-NPR Health Poll.
Additionally, 12% of all respondents said that cost drove them to purchase prescription medication outside the U.S.Truven Health Analytics®, part of the IBM Watson Health business, and NPR conduct a nationwide bimonthly poll to gauge attitudes and opinions on a wide range of health issues.Following are the poll’s key findings:
Cost Plays a Factor
: A third (33%) of respondents who received a prescription for medication looked for the cost of the medication before filling the prescription, a rate that decreases with increasing age. The highest rate (64%) is for millennials.
Side Effects Conjure Concerns
: The reason mentioned most often by respondents who stopped taking their prescribed medication was Side Effects (29%), followed by Didn’t Need (17%), Felt Better (16%), Not Working (15%), and Cost (10%).
Medication Adherence Lags among the Well-Compensated and Educated
: A quarter (25%) of all respondents who filled their prescription missed a dose of the medication, a rate that increases among respondents with higher levels of education and income.
“While barriers to medication adherence appear to vary, some patients seem to be weighing the expense of prescription drugs as a factor in their decision to purchase and follow through with a full course of treatment, ” said Anil Jain, MD, Vice-President and Chief Health Informatics Officer, Value-Based Care, IBM Watson Health. “Further studies should be conducted to investigate barriers to adherence. Meanwhile, healthcare providers and policy makers should consider how drug costs may impact adherence rates as they develop population health strategies.”According to the Centers for Medicare & Medicaid Services, retail prescription drug spending increased nine percent to $324.6 billion from 2014 to 2015, the most recent data available.To date, the Truven Health Analytics-NPR Health Poll has explored numerous health topics, including generic drugs, vaccines, data privacy, narcotic painkillers, and sports-related concussions. NPR archives reports on the surveys online at the Shots health blog here. Truven Health maintains a library of poll results here. The Truven Health Analytics-NPR Health Poll is powered by the Truven Health PULSE® survey, an independently funded, nationally representative, multimodal poll that collects information about health-related behaviors and attitudes and healthcare use from 80, 000 U.S. households annually. The results depicted from the 2017 survey represent responses from 3, 003 survey participants interviewed from June 1 – 15, 2017. The margin of error is +/- 1.8 percentage points.
Truven Health Analytics®, part of the IBM Watson Health™ business, provides market-leading performance improvement solutions built on data integrity, advanced analytics and domain expertise. For more than 40 years, our insights and solutions have been providing hospitals and clinicians, employers and health plans, state and federal government agencies, life sciences companies and policymakers, the facts they need to make confident decisions that directly affect the health and well-being of people and organizations in the US and around the world. The company was acquired by IBM in 2016 to help form a new business, Watson Health. Watson Health aspires to improve lives and give hope by delivering innovation to address the world’s most pressing health challenges through data and cognitive insights.
Truven Health Analytics owns some of the most trusted brands in healthcare, such as MarketScan®, 100 Top Hospitals®, Advantage Suite®, Micromedex®, Simpler® and ActionOI®. Truven Health has its principal offices in Ann Arbor, MI, Chicago, IL, and Denver, CO.
Click here to continue>>
News from our partners.
